StonvexLoading…
StonvexStonvexStonvexCore line items from VTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.83B | $4.92B | $4.50B | $4.13B |
Operating Income | $204.32M | $-8.00M | $-115.58M | $-94.14M |
Net Income | $261.52M | $88.35M | $-30.30M | $-40.93M |
EPS (Diluted) | $0.54 | $0.19 | $-0.10 | $-0.12 |
Total Assets | $27.59B | $26.19B | $24.73B | $24.16B |
Total Liabilities | $14.63B | $15.05B | $14.88B | $13.67B |
Cash & Equivalents | $741.07M | $897.85M | $508.79M | $122.56M |
Free Cash Flow OCF − CapEx | $-1.28B | $-1.20B | $470.40M | $219.47M |
Shares Outstanding | 462.62M | 416.37M | 405.67M | 403.45M |